Nihon Trim (6788) · FactFirst stated

Higher Revenue and Segment Profit in the Healthcare-Related Business for Full-Year FY2024

First written in FY2024. . Latest entry: FY2024.

1entries

1years

0from disclosures

How it moved

Same theme, other companies

Higher revenue and profit from increased sales of therapeutic drugs and other products in the healthcare business, together with expense controlA theme 2 companies write about · 0 as a headwind · 10 as a tailwind

1 other company's latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Full recordFilings, disclosures and news, newest first

FY2024First statedAnnual report
「Revenue from the healthcare-related business was ¥2,636 million, up 15.3% year on year, and segment profit was ¥392 million, up 58.1%.」
The Medical-Related business reported higher revenue and profit for FY2024, with segment income increasing 58.1%.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

No upcoming earnings preview for Nihon Trim yet.

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.